These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6745736)

  • 1. Effect of various oral contraceptive combinations on dysmenorrhea.
    Milsom I; Andersch B
    Gynecol Obstet Invest; 1984; 17(6):284-92. PubMed ID: 6745736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea.
    Milsom I; Sundell G; Andersch B
    Contraception; 1990 Nov; 42(5):497-506. PubMed ID: 2125545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
    Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
    Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.
    Vercellini P; Frontino G; De Giorgi O; Pietropaolo G; Pasin R; Crosignani PG
    Fertil Steril; 2003 Sep; 80(3):560-3. PubMed ID: 12969698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic.
    Robinson JC; Plichta S; Weisman CS; Nathanson CA; Ensminger M
    Am J Obstet Gynecol; 1992 Feb; 166(2):578-83. PubMed ID: 1536234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
    Hauksson A; Ekström P; Juchnicka E; Laudański T; Akerlund M
    Acta Obstet Gynecol Scand; 1989; 68(1):31-4. PubMed ID: 2801028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
    Skouby SO
    Int J Fertil; 1987; 32 Suppl():45-8. PubMed ID: 2906346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard treatment of dysmenorrhea with special reference to treatment with spasmolytics and hormones.
    Osler M
    Acta Obstet Gynecol Scand Suppl; 1979; 87():69-72. PubMed ID: 288297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with two low dosage estrogen progestogen preparations (SH 7.1122 and SH B 259 AB)].
    Leone U; Di Girolamo V
    Minerva Ginecol; 1980 Sep; 32(9):791-800. PubMed ID: 7012684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma.
    Taniguchi F; Enatsu A; Ota I; Toda T; Arata K; Harada T
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():116-20. PubMed ID: 26115056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are combined oral contraceptives appropriate therapy for primary dysmenorrhea?
    Goodwin JH
    J Nurse Midwifery; 1980; 25(2):17-9. PubMed ID: 6898647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis.
    Chapron C; Souza C; Borghese B; Lafay-Pillet MC; Santulli P; Bijaoui G; Goffinet F; de Ziegler D
    Hum Reprod; 2011 Aug; 26(8):2028-35. PubMed ID: 21642638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prescription contraceptive methods in the UK general population: a primary care study.
    Cea-Soriano L; García Rodríguez LA; Machlitt A; Wallander MA
    BJOG; 2014 Jan; 121(1):53-60; discussion 60-1. PubMed ID: 24118863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiologic study of young women with dysmenorrhea.
    Andersch B; Milsom I
    Am J Obstet Gynecol; 1982 Nov; 144(6):655-60. PubMed ID: 7137249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogens in association in contraception].
    De Lignières B
    Rev Prat; 1979 Apr; 29(21):1737-42. PubMed ID: 472621
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.